Introduction to pharmacology

53,246views

Introduction to pharmacology

Watch later

Watch later

Asthma
Chronic obstructive pulmonary disease (COPD): Clinical
Asthma: Clinical
Epidural hematoma
Subdural hematoma
Intracerebral hemorrhage
Concussion and traumatic brain injury
Hypersensitivity skin reactions: Clinical
Otitis media
Salmonella (non-typhoidal)
Hypertension: Clinical
Hypertension
Hypertension: Pathology review
Hypertensive disorders of pregnancy: Clinical
Eustachian tube dysfunction
Vesiculobullous and desquamating skin disorders: Pathology review
Skin cancer: Pathology review
Viral exanthems of childhood: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Cerebral palsy
Gallbladder disorders: Pathology review
Pulmonary valve disease
Advanced cardiac life support (ACLS): Clinical
Skin anatomy and physiology
Introduction to the somatic and autonomic nervous systems
Hypospadias and epispadias
Abnormal labor: Clinical
Kawasaki disease
Shock
Neonatal ICU conditions: Clinical
Seizures and epilepsy
Antigout medications
Enzyme function
Primary biliary cholangitis
Congenital adrenal hyperplasia
Cirrhosis
Basal ganglia: Direct and indirect pathway of movement
Introduction to the central and peripheral nervous systems
Diabetes mellitus: Clinical
Newborn management: Clinical
Muscarinic antagonists
Primary sclerosing cholangitis
Gallstones
Benign hyperpigmented skin lesions: Clinical
Antiplatelet medications
Nephrotic syndromes: Pathology review
Renal failure: Pathology review
Anatomy clinical correlates: Viscera of the gastrointestinal tract
The role of the kidney in acid-base balance
Gastrointestinal system anatomy and physiology
Chronic kidney disease
Introduction to the immune system
Innate immune system
Hyponatremia
Measuring cardiac output (Fick principle)
Pneumonia: Pathology review
Osteoarthritis
Introduction to pharmacology
Anatomy and physiology of the eye
Optic pathways and visual fields
Photoreception
Wolff-Parkinson-White syndrome
Cor pulmonale
Chronic kidney disease: Clinical sciences
Esophageal cancer
Psoriasis
Appendicitis: Pathology review
Chronic obstructive pulmonary disease: Clinical sciences
Febrile seizure (pediatrics): Clinical sciences
Anatomy clinical correlates: Cerebral hemispheres
Ischemic stroke
Stroke: Clinical
Bone tumors: Pathology review
Electrolyte disturbances: Pathology review
Anatomy of the female urogenital triangle
Vertigo: Pathology review
Hypothyroidism
Phenylketonuria (NORD)
Disorders of carbohydrate metabolism: Pathology review
Parasympathetic nervous system
Peripheral artery disease: Pathology review
Nervous system anatomy and physiology
Pain management during labor: Clinical sciences
Childhood oral health: Information for patients and families (The Primary School)
Pneumothorax: Clinical sciences
Blood histology
Non-steroidal anti-inflammatory drugs
Iron deficiency and iron deficiency anemia (pediatrics): Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Introduction to the skeletal system
Approach to shock: Clinical sciences
Rheumatoid arthritis

Transcript

Watch video only

Pharmacology is the study of medications, or chemical compounds, which interact with various living systems, from tiny molecules to cells, to tissues and whole organisms in order to produce a certain effect.

Every day, more and more new medications are designed to fight diseases, from infections to cancer, heart failure, and depression. But the process of developing a new medication can take a lot of time and money, and it typically consists of three steps. Step 1 is discovery, and that’s when a candidate compound is picked out as a possible therapeutic agent for a specific disease. Step 2 is preclinical research, during which this compound is tested on cell cultures and animals, like mice and rats, mainly to see if it causes any serious harm on living organisms. And, finally, step 3 is clinical development, during which clinical trials are performed. That’s where the compound is tested on humans to see if it’s safe and effective in treating diseases.

For a new medication, clinical trials are done in 4 phases, which can be remembered with the mnemonic “All medications need the SEAL of approval,” which stands for Safety, Efficacy, Approval, and Long term. Phase I trials test the medication in a small group of healthy individuals to see if it’s Safe for humans.

Phase II trials aim to find out more about how Effective the medication is or how well it works at a certain dose. This is done by testing it on a moderately sized group of individuals affected by the condition in question.

In phase III trials, the new medication is compared to the standard treatment to find out if it’s actually just as good as or even better than the existing one. Phase III trials generally involve a much larger number of individuals, and aim to replicate the exact setting in which the medication will be administered in real life, which will then be used as the basis for Approval by regulatory organizations for the market.

This whole process can take up to 10 years or more, depending on the compound. But if all this goes well- congratulations! We’ve got a new medication!

Now, that new medication will have at least three names- a chemical one, describing its chemical structure and used mostly in scientific studies, like N-acetyl-p-aminophenol; a generic name, which is usually a shortened version of the chemical name and is mostly used by health professionals, such as paracetamol or acetaminophen; and one or more brand or trade names, given by the pharmaceutical companies that make the medication, such as Panadol or Tylenol.

Okay, but the journey of drug development hasn’t finished quite yet. Once a medication reaches the marketplace, there’s phase IV, which is a final phase of safety surveillance that looks for Long term or rare side effects that might have been missed. If it’s found to be unsafe, a recall and ban might be needed.

Alright, now, once a medication is administered, it starts interacting with the body. This interaction can be broken down into pharmacokinetics and pharmacodynamics.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e" McGraw Hill / Medical (December 5, 2017)
  4. "First Aid for the USMLE Step 1 2020, Thirtieth edition" McGraw-Hill Education (2020)
  5. "Drug interactions: principles and practice" Aust Prescr (2012)
  6. "Pharmacodynamic Drug-Drug Interactions" Clinical pharmacology and therapeutics (2019)
  7. "When less is more – efficacy with less toxicity at the ED50" Br J Clin Pharmacol (2017)
  8. "The Drug Development Process " FDA (2021, August 2)